Literature DB >> 24554006

Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?

Giovanni Musso1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24554006     DOI： 10.1007/s00125-014-3192-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  31 in total

1.  Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance?

Authors:  Natalia N Rudovich; Martin O Weickert; Juergen Machann; Andreas F H Pfeiffer
Journal:  J Hepatol       Date:  2010-03-15       Impact factor: 25.083

2.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

3.  Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis.

Authors:  Giovanni Musso; Maurizio Cassader; Franco De Michieli; Francesca Saba; Simona Bo; Roberto Gambino
Journal:  Am J Clin Nutr       Date:  2011-08-24       Impact factor: 7.045

4.  Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

Authors:  Isabelle Gerin; Laure-Alix Clerbaux; Olivier Haumont; Nicolas Lanthier; Arun K Das; Charles F Burant; Isabelle A Leclercq; Ormond A MacDougald; Guido T Bommer
Journal:  J Biol Chem       Date:  2010-08-22       Impact factor: 5.157

5.  Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.

Authors:  Masateru Ushio; Yoshihiko Nishio; Osamu Sekine; Yoshio Nagai; Yasuhiro Maeno; Satoshi Ugi; Takeshi Yoshizaki; Katsutaro Morino; Shinji Kume; Atsunori Kashiwagi; Hiroshi Maegawa
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-28       Impact factor: 4.310

Review 6.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

Review 7.  Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Prog Lipid Res       Date:  2012-12-01       Impact factor: 16.195

Review 8.  Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.

Authors:  Chrysi Koliaki; Michael Roden
Journal:  Mol Cell Endocrinol       Date:  2013-06-12       Impact factor: 4.102

9.  Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

Authors:  Derrick M Van Rooyen; Lay T Gan; Matthew M Yeh; W Geoffrey Haigh; Claire Z Larter; George Ioannou; Narci C Teoh; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2013-03-07       Impact factor: 25.083

10.  Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Christopher P Cannon; Robert P Giugliano; Michael A Blazing; Robert A Harrington; John L Peterson; Christine McCrary Sisk; John Strony; Thomas A Musliner; Carolyn H McCabe; Enrico Veltri; Eugene Braunwald; Robert M Califf
Journal:  Am Heart J       Date:  2008-09-02       Impact factor: 4.749
View more
  3 in total

Review 1.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

2.  Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet.

Authors:  Simin Feng; Zhuqing Dai; Anna B Liu; Jinbao Huang; Nihal Narsipur; Grace Guo; Bo Kong; Kenneth Reuhl; Wenyun Lu; Zisheng Luo; Chung S Yang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-07       Impact factor: 4.698

Review 3.  Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Authors:  Maria Grazia Clemente; Claudia Mandato; Marco Poeta; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.